Invention Grant
- Patent Title: Ophthalmic formulations of methotrexate
-
Application No.: US17932426Application Date: 2022-09-15
-
Publication No.: US12005060B2Publication Date: 2024-06-11
- Inventor: Dean Eliott , Stephen Gitu Machatha , Pramod Sarpotdar , Tomasz Stryjewski
- Applicant: Aldeyra Therapeutics, Inc.
- Applicant Address: US MA Lexington
- Assignee: Aldeyra Therapeutics, Inc.
- Current Assignee: Aldeyra Therapeutics, Inc.
- Current Assignee Address: US MA Lexington
- Agency: Dechert LLP
- Agent Andrea L. C. Reid; Joseph W. Arico
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61K9/00 ; A61K47/02 ; A61K47/26
Abstract:
The present disclosure provides formulations of methotrexate for ocular administration, including intravitreal administration, and use of the formulations for treating proliferative vitreoretinopathy (PVR), intraocular lymphoma (e.g., PVRL), and intraocular inflammation.
Public/Granted literature
- US20230018197A1 OPHTHALMIC FORMULATIONS OF METHOTREXATE Public/Granted day:2023-01-19
Information query
IPC分类:
